These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7705452)

  • 1. Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain.
    Hume SP; Ashworth S; Opacka-Juffry J; Ahier RG; Lammertsma AA; Pike VW; Cliffe IA; Fletcher A; White AC
    Eur J Pharmacol; 1994 Dec; 271(2-3):515-23. PubMed ID: 7705452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse.
    Laporte AM; Lima L; Gozlan H; Hamon M
    Eur J Pharmacol; 1994 Dec; 271(2-3):505-14. PubMed ID: 7705451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635.
    Hall H; Lundkvist C; Halldin C; Farde L; Pike VW; McCarron JA; Fletcher A; Cliffe IA; Barf T; Wikström H; Sedvall G
    Brain Res; 1997 Jan; 745(1-2):96-108. PubMed ID: 9037397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of the binding of [3H]WAY-100635, a novel 5-hydroxytryptamine1A receptor antagonist, to rat brain.
    Khawaja X; Evans N; Reilly Y; Ennis C; Minchin MC
    J Neurochem; 1995 Jun; 64(6):2716-26. PubMed ID: 7760052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
    Khawaja X; Ennis C; Minchin MC
    Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist.
    Fletcher A; Forster EA; Bill DJ; Brown G; Cliffe IA; Hartley JE; Jones DE; McLenachan A; Stanhope KJ; Critchley DJ; Childs KJ; Middlefell VC; Lanfumey L; Corradetti R; Laporte AM; Gozlan H; Hamon M; Dourish CT
    Behav Brain Res; 1996; 73(1-2):337-53. PubMed ID: 8788530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.
    Forster EA; Cliffe IA; Bill DJ; Dover GM; Jones D; Reilly Y; Fletcher A
    Eur J Pharmacol; 1995 Jul; 281(1):81-8. PubMed ID: 8566121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [11C]WAY 100635: a radioligand for imaging 5-HT1A receptors with positron emission tomography.
    Mathis CA; Simpson NR; Mahmood K; Kinahan PE; Mintun MA
    Life Sci; 1994; 55(20):PL403-7. PubMed ID: 7968222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative autoradiographic characterisation of the binding of [3H]WAY-100635, a selective 5-HT1A receptor antagonist.
    Khawaja X
    Brain Res; 1995 Mar; 673(2):217-25. PubMed ID: 7606435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Farde L; Ginovart N; Luthra SK; Gunn RN; Bench CJ; Sargent PA; Grasby PM
    Nucl Med Biol; 1998 Apr; 25(3):215-23. PubMed ID: 9620626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia.
    Burnet PW; Eastwood SL; Harrison PJ
    Neurochem Int; 1997 Jun; 30(6):565-74. PubMed ID: 9152998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical in vitro and in vivo binding of [3H]S-14506 to brain 5-HT1A receptors.
    Lima L; Laporte AM; Gaymard C; Spedding M; Mocaër E; Hamon M
    J Neural Transm (Vienna); 1997; 104(10):1059-75. PubMed ID: 9503258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB; Koek W
    Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two C-methyl derivatives of [11C]WAY-100635--effects of an amido alpha-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey.
    McCarron JA; Marchais-Oberwinkler S; Pike VW; Tarkiainen J; Halldin C; Sóvagó J; Gulyas B; Wikström HV; Farde L
    Mol Imaging Biol; 2005; 7(3):209-19. PubMed ID: 15912425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Ginovart N; Luthra SK; Bench CJ; Grasby PM; Wikström H; Barf T; Cliffe IA; Fletcher A; Farde L
    Nucl Med Biol; 1996 Jul; 23(5):627-34. PubMed ID: 8905828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635.
    Pike VW; McCarron JA; Lammertsma AA; Osman S; Hume SP; Sargent PA; Bench CJ; Cliffe IA; Fletcher A; Grasby PM
    Eur J Pharmacol; 1996 Apr; 301(1-3):R5-7. PubMed ID: 8773468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.